Find, compare & contact
Sodium lauryl sulfoacetate
API Manufacturers & Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Sodium lauryl sulfoacetate API 1847-58-1?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Sodium lauryl sulfoacetate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Sodium lauryl sulfoacetate
- Synonyms:
- Lathanol , Lathanol LAL , Sulfoacetic acid dodecyl ester S-sodium salt
- Cas Number:
- 1847-58-1
- DrugBank number:
- DB13157
- Unique Ingredient Identifier:
- D0Y70F2B9J
General Description:
Sodium lauryl sulfoacetate, identified by CAS number 1847-58-1, is a notable compound with significant therapeutic applications. Sodium lauryl sulfoacetate is a wetting agent and surfactant used in enema-type laxative products.
Indications:
This drug is primarily indicated for: Sodium lauryl sulfoacetate is not an active pharmacological ingredient in pharmaceutical preparations and so has no official indication. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Pharmacodynamics:
Sodium lauryl sulfoacetate exerts its therapeutic effects through: Sodium lauryl sulfoacetate acts as a wetting agent and surfactant in pharmaceutical preparations . It is currently used in enema-type laxatives. The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.
Classification:
Sodium lauryl sulfoacetate belongs to the class of organic compounds known as organosulfonic acids. These are compounds containing the sulfonic acid group, which has the general structure RS(=O)2OH (R is not a hydrogen atom), classified under the direct parent group Organosulfonic acids. This compound is a part of the Organic compounds, falling under the Organic acids and derivatives superclass, and categorized within the Organic sulfonic acids and derivatives class, specifically within the Organosulfonic acids and derivatives subclass.
Categories:
Sodium lauryl sulfoacetate is categorized under the following therapeutic classes: Alimentary Tract and Metabolism, Drugs for Constipation, Enemas. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Sodium lauryl sulfoacetate is a type of Gastrointestinal Agents
Gastrointestinal Agents belong to the pharmaceutical API category that focuses on treating disorders and ailments related to the digestive system. These agents play a crucial role in addressing various gastrointestinal conditions, such as acid reflux, ulcers, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD).
One of the key types of gastrointestinal agents is proton pump inhibitors (PPIs), which work by reducing the production of stomach acid. PPIs help in treating conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. Another essential class of agents is antacids, which neutralize excessive stomach acid, providing relief from heartburn and indigestion.
Gastrointestinal agents also include antispasmodics that alleviate abdominal cramps and spasms associated with conditions like IBS. These drugs work by relaxing the smooth muscles of the digestive tract. Additionally, there are drugs categorized as laxatives that aid in relieving constipation by promoting bowel movements.
Moreover, certain gastrointestinal agents act as antiemetics, effectively reducing nausea and vomiting. These drugs are particularly useful for patients undergoing chemotherapy or experiencing motion sickness.
Pharmaceutical companies develop and manufacture a wide range of gastrointestinal agents in various forms, including tablets, capsules, suspensions, and injections. These agents are typically formulated using active pharmaceutical ingredients (APIs) and other excipients to ensure their efficacy and safety.
In conclusion, gastrointestinal agents form a vital category of pharmaceutical APIs, providing relief from digestive disorders and improving overall gastrointestinal health. The availability of diverse agents catering to different conditions ensures that patients can receive targeted treatment for their specific gastrointestinal needs.
